摘要
目的探讨剖宫产术后子宫瘢痕妊娠(CSP)的诊疗方法和临床效果。方法 40例剖宫产术后子宫瘢痕妊娠患者,对其诊断方式、治疗方法及血人绒毛膜促性腺激素(β-HCG)结果等进行临床分析,对其相关的资料和诊疗信息进行回归性分析和探讨总结。结果实施治疗后,甲氨蝶呤(MTX)联合米非司酮患者的β-HCG为(1102.42±472.17)U/L,米非司酮联合米索前列醇患者的β-HCG为(1136.59±477.42)U/L,相比于治疗前结果都发生了明显下降,治疗前后结果对比,差异具有统计学意义(P<0.05)。结论实施完善的产前检查工作,及早开展诊断,对患者的有关剖宫产指征进行科学把握,对于剖宫产术后子宫瘢痕妊娠患者有很好的临床效果,能够有效降低β-HCG大小,值得在临床上推广应用。
Objective To investigate diagnosis method and clinical effect of cesarean scar pregnancy （CSP） after cesarean section. Methods There were 40 patients with cesarean scar pregnancy after cesarean section, and their diagnosis mode, treatment method and serum human chorionic gonadotropin （β-HCG） level were clinically analysis. Their related data and treatment information were taken for regression analysis and investigated summarization. Results After treatment, β -HCG in patients receiving combination of methotrexate （MTX） and mifepristone was （1102.42 ± 472.17）U/L, and that in patients receiving combination mifepristone and misoprostol was （1136.59 ± 477.42）U/L. These results were obviously decreased from those before treatment, and the difference before and after treatment had statistical significance （P〈0.05）. Conclusion Implement of thorough prenatal examination, early diagnosis, and scientifically control of cesarean section indication can all provide good clinical effect for cesarean scar pregnancy after cesarean section. This method can effectively reduce β-HCG size, and it is worthy of clinical promotion and application.
出处
《中国实用医药》
2015年第16期20-22,共3页
China Practical Medicine
关键词
剖宫产术后
子宫瘢痕妊娠
临床分析
After cesarean section
Cesarean scar pregnancy
Clinical analysis
